Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD, USA.
Am J Kidney Dis. 2012 Jul;60(1):47-53. doi: 10.1053/j.ajkd.2012.01.023. Epub 2012 Apr 6.
Chronic kidney disease is a high-risk condition for a variety of adverse safety events, yet little is known about differential rates of safety events across racial groups with decreased kidney function. We sought to examine the incidence of an array of disease-specific adverse safety events in black versus nonblack patients with decreased estimated glomerular filtration rate (eGFR).
Retrospective observational study of a national US Veterans Affairs cohort.
SETTINGS & PARTICIPANTS: Veterans with eGFR <60 mL/min/1.73 m(2) and one or more hospitalization during federal fiscal year 2005 (n = 70,154).
Self-reported race/ethnicity dichotomized as black or nonblack.
Hospital discharge coding for Agency for Healthcare Research and Quality (AHRQ) patient safety indicators (PSIs), laboratory records for detection of hyperkalemia and hypoglycemia, and pharmacy records to determine dosing of 4 selected medications.
Relationship between race and disease-specific patient safety events.
Black veterans were more likely than nonblack veterans to experience one type of safety event (33% vs 32%, respectively) and multiple types of safety events (32% vs 23%, respectively; both P < 0.001). After adjustment, black veterans were 11% and 36% more likely to have at least one episode of hyperkalemia and hypoglycemia, respectively, than nonblack veterans, but were 14% less likely to experience a medication error (all P < 0.001). There was no association between the occurrence of AHRQ PSIs and race after adjustment.
Use of administrative data has a risk of imprecision in coding; Veterans Affairs cohort may limit generalizability.
Black veterans with decreased eGFR are more likely to experience a broad array of safety events than nonblacks with decreased eGFR, with a preponderance of metabolic disturbances rather than medication errors or AHRQ PSIs. The differential safety phenotype in blacks versus nonblacks may have implications for preventive strategies to improve patient safety in an integrated health care system.
慢性肾脏病是多种不良安全事件的高危状态,但对于肾功能下降的不同种族人群的安全事件发生率差异知之甚少。我们旨在研究肾小球滤过率(eGFR)降低的黑人和非黑人患者中一系列特定疾病不良安全事件的发生率。
对美国退伍军人事务部的全国队列进行回顾性观察研究。
eGFR<60 mL/min/1.73 m²且在联邦财政年度 2005 年期间有一次或多次住院治疗的退伍军人(n=70154)。
自我报告的种族/民族分为黑人或非黑人。
通过医疗保健研究与质量局(AHRQ)患者安全指标(PSI)的出院编码、检测高钾血症和低血糖症的实验室记录以及确定 4 种选定药物剂量的药房记录来确定是否发生疾病特异性的患者安全事件。
种族与特定疾病的患者安全事件之间的关系。
黑人退伍军人比非黑人退伍军人更有可能发生一种安全事件(分别为 33%和 32%)和多种安全事件(分别为 32%和 23%;均 P<0.001)。调整后,黑人退伍军人发生高钾血症和低血糖症的风险分别比非黑人退伍军人高 11%和 36%,但发生药物错误的风险低 14%(均 P<0.001)。调整后,种族与 AHRQ PSI 的发生之间没有关联。
使用行政数据存在编码不精确的风险;退伍军人事务部队列可能会限制其普遍性。
肾小球滤过率降低的黑人退伍军人比肾小球滤过率降低的非黑人退伍军人更有可能经历广泛的安全事件,其以代谢紊乱为主,而不是药物错误或 AHRQ PSI。黑人和非黑人之间的安全表型差异可能对改善综合医疗保健系统中患者安全的预防策略有影响。